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Preface 
The work of this thcsis has been carricd out undcr the guidances or Proi'Lssnr 
Hiroshi Uyama at Departmcnt of Applicd Chemistry. Graduate School or Engineering. 
Osaka University and Dr. Tctsuji Yamaoka. Director of Departmcnt or Biomedical 
Enginecring. Advanced Mcdical Enginccring Ccntcr. National Cardiovascular Center 
Rcsearch Institute. Japan. 
Thc objectivcs of this thesis arc to manipulate functional cells uSll1g \\ell 
controlled ill vitro microenvironmcnts composcd of (I) substrates on which cells arc 
adhering, (2) chcmical substanccs leading to cell differentiation. growth. or preservation. 
(3) cellular gcometry such as monolaycr. suspcnsion. or sphcroid. (4) culture medium 
(aeration. pH. nutrients. flow-condition and so on). This thcsis focused on producing 
beating cardiac cells from MSC and on preserving isolatcd hcpatocytes in bioartificial 
liver assist system. 
The originalities of this thesis are thc achievcments 111 obtaining the beating 
cardiomyocytes from autogenic bone marrow massencymal stcm cell. and the 
preservation of hepatocytes in bioartiticial liver assist system at room temperature by 
control in vitro microenvironment. 
Thc author wishes that thc fundamental practicablc results obtained in this 
work will provide useful information and suggcstion ror furthcr development in tis<,uc 
enginecring and regcnerative medicine. 
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General Introduction 
Tissue engineering and regenerative medicine 
Tissue engineering and regenerative medicine aim to repair damaged tissue by 
replacing them with healthy and functional ones. Various somatic stem cells. embryonic 
stem cells, and specific functional cells were attracting great attention as their cell 
sources. Three types of potential cell sources were proposed; I) allogeneic sources 2) 
xenogenic sources and. 3) autogeneic sources [I]. 
The microenvironment for the cells. which is called "niche", has been found to 
be sophisticated system and plays important roles in cell proliferation, differentiation. 
and functioning in vivo. Hence. how to design the artificial niche in vitro is one of the 
biggest challenges in tissue engineering. Scientists have been preparing various 
scaffolds with well designed interfaces between cells and scaffolds using synthetic 
polymer or natural substance to find out the most appropriate materials for cell growth 
and function. A variety of growth factors such as basic fibroblast growth factor (bFGF) 
or insulin-like growth factor (IGF) is very useful for to cells growth in vitro [2]. and 
various kinds of cell-adhesion molecules, such as RGD and REDV, are knovm to 
improve cell-scaffold interactions [3]. 
Recently, many researchers have switched their attention into the effect of 
microenvironment on cell signaling with regard to cell differentiation [4]. Chemical 
methods to differentiate mesenchymal stem cells (MSC) into osteogenic cells or 
chondrogenic cells \vere established. However. myocardial difTerentiation of MSC was 
sti II under debate [5-6]. 
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Cell preservation is also a big challenge in tissue engineering. Cryopreservation 
is a general technique for the cell preservation. A chemical substance such as dimethyl 
sulfoxide (OM SO), glycerol, and propylene glycol was used as cryoprotectant to protect 
cell from freezing damage. However, some functional cells like hepatocytes lost their 
function during the cryopreservation. Cho, H.R. et al. rep0l1ed that the viability of 
hepatocytes decreased to lower than 60% when preserved at low temperature IJ1 
University of Wisconsin (UW) and Euro-Collins (EC) solutions for 48 hours [7]. Not 
only the hepatocytes but also the other valuable cells generally lost their viability with 
preservation. For example, the viability of peripheral blood stem cell and hemopoietic 
progenitor cell decreased to less than 50% when preserved for 3 days at room 
temperature [8]. 
The objective of present study is to manipulate functional cells uSlJ1g well 
controlled in vitro microenvironments composed of (I) substrates on which stem cells 
are adhering, (2) chemical substances leading to cell differentiation, growth. or 
preservation, (3) cellular geometry such as monolayer, suspension, or spheroid, (4) 
culture medium (aeration, pH, nutrients, flow-condition and so on). Present study 
focused on producing beating cardiac cells from MSC and on preserving isolated 
hepatocytes in bioartificial liver assist system. 
Beating cardiac cells 
Cardiomyocyte transplantation for patients with ischemic heart disease or 
dilated cardiomyopathies is great potential therapeutic option to enhance the contracti Ie 
function of the failing heart. However, the best cell sources for clinical cardiomyocyte 
transplantation are still under debate. Allogenic source including human embryonic 
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stem cells or fatal allogenic cardiomyocytes have been proposed, but there still remains 
an ethical issue. Genetically engineered animal cardiomyocytes have been studied for 
reducing the rejection reaction in vivo, which takes still long period time to secure the 
safety. Most promising cell source is autogeneic. Isolating cardiomiocytes from the 
patient hearts is unrealistic at present, and autologous skeletal muscle precursors, 
fibroblast, or mesenchymal stem cells have been studied so far [9]. However, since 
beating cardiomyocytes are more promising [10], in the present study focusing on to 
differentiate bone marrow mesenchymal stem cells (BMSCs) into "beating" 
cardiomyocytes. 
Producing autologous beating cardiomyocytes is then attractive Issue for 
cell-based therapy. The most crucial part is how to differentiate them to cardiomyocytes 
in vitro and how to maintain the beating feature. The effect of extracellular matrix 
(ECM) proteins such as collagen type I, collagen type IV, gelatin. laminin, fibronectin, 
Matrigel™ (mixture of laminin, collagen type IV, heparan sulfate proteoglycans and 
entactin). and Cardiogcl™ (mixture of collagen type I and III, glycoproteins, laminin, 
fibronectin and proteoglycans) on cell viability, proliferation rate, and cardiomyocyte 
gene expression were reported [11-12]. However, the effects of ECM on 
cardiomyocytes beating and differentiation behaviors were not fully discussed. 
There is no certain induction method for BMSCs differentiation into beating 
cardiomyocytes. Many researchers observed cardiac gene expression in MSCs treated 
with various inducers [13-15] or passage number [16]. but they do not beat 
spontaneously. Wakitani, S. et al and Makino, S. et al. reported that murine BMSCs 
were differentiated to beating cardiomyocytes-like cells in vitro by exposing to 
DNA-demethylating agent 5-azacytidine [13-14]. This is in contrast with a report stated 
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that the functional cardiac cells and gene expression were not obtained after treated with 
5-azacytidine l51· 
Therefore, in part I. eflects of microenvironment on various behaviors of cardiac 
cells were studied. In chapter 1, neonatal primary cardiomyocytes \vas cultured on 
variolls extracellular matrix (ECM) proteins (gelatin, collagen type-I. and fibronectin). 
The effect on beating duration and intracellular cardiac gene expression (troponin T 
type-2 and troponin C type-I) and cardiac differentiation marker gene (troponin C 
type-2) \vere evaluated. The beating period and the expression of troponin T type-2, 
troponin C type-I of cardiomyocytes cultured on gelatin-coated dish were longer and 
higher than the others. The effect of ECM on beating duration will be further discussed 
in this chapter. 
In chapter 2, the difTerentiation enIciency of murine embryonal carcinoma (EC) 
stern cells (PI9.CL6) on various ECM proteins (gelatin, collagen type-I, and 
fibronectin) was studied. The beating colonies and intracellular cardiac gene expression 
and cardiac differentiation marker gene were evaluated. For cardiac differentiation of
P 19.CL6 cells. troponin T type-2 expression on gelatin- or fibronectin-eoated dish was 5 
times higher than that on collagen type I-coated dish or polystyrene dish 11 days after 
induction. The effect of ECM proteins on differentiation behavior was discussed in this 
chapter. The fundamental infonnation from chapter I and chapter 2 would be important 
for cardiac diflerentiation of various stem cells including autologous BMSCs. 
[n chapter 3. effect of chemical inducer. substrates, and cell geometry 
(suspension and monolayer induction) on differentiation of bone marrow MSCs to 
beating cardiomyocytes were studied. The number of myotube-like cells and the 
expression of troponin T type-2. troponin C type-I, and troponin C type-2 were 
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evaluated. In this chapter, the difTerentiation of BMSCs to beating cardiomyocytes was 
successfully achieved. 
Preservation of isolated hepatocytes in bioartificialliver asssit system 
Hepatocyte-based treatments for fulminant or chronic hepatitis have been 
attracting great attention so far. At present. injection of hepatocytes isolated from 
unused donor livers and bioartificial liver assist systems (BAL) is used for treating acute 
liver failures and liver-based metabolic defects [17-20]. A large number of hepatocytes 
must be prepared for emergency care and for repeated treatment l21]. However, because 
the isolation and reconstruction into 3D structure of the hepatocytes would take long 
time with complex steps. the metabolic activity rapidly decreased during the preparation 
process. However, to maintain the specific functions of the hepatocytes by conventional 
cryoperservation is difficult [22-27]. 
Various strategies to maintain cell functions have been proposed. Watts, P. et 
al. and Mckay, Gc. et al. reported that monolayer culture is superior to suspension 
culture in preserving hepatocytes [28-29]. Kakinoki. R. et al have succeeded in storing 
peripheral nerves for over a month using green tea polyphenol [30], and Hyon, S.H. et 
al. reported that grecn tea polyphenol also preserved the rat pancreatic islet for ove,r 2 
months l31]. 
I n the part I I. the microenvironment fllr preserving hepatocyte functions were 
studied. Before preserving the isolated hepatocytes in 3D bioreactor, the improvement 
of hepatocytes functions in radial-flow bioreactor for BAL was studied in chapter 4. 
BAL for treating acute liver failure has been studied for 50 years. Majority of the 
research has been conducted using hollow fiber perfusion-type bioreactor. However, the 
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efficiency in supplying oxygen and nutrients IS not satisfactory. 
In this chapter. 
radial-flow bioreactor was developed for prolonged hepatocyte functi
ons. This radial 
flow allows the medium culture to flow in the bioreactor entirely. In 19
85, it is reported 
that spheroid structure of the hepatocytes are important for maintainin
g their functions 
[32]. In this chapter. bioreactor in which hepatocytes are cultured 
in spheroid-like 
structure was established by using hydrophilic non-woven matrices. 
The non-woven 
sheet was polytetrafluorocthlyne (PTFE) non-woven fabric coated \V'
ith copolymer of 
poly (y-methyl-L-glutamate) (PMLG) and the polyurethane (PA U-coa
ted PTFE). The 
hepatocyte functions were kept at high value for I week and wi!! be des
cribed further in 
this chapter. 
In chapter 5. new technique to preserve the cultured hepatocytes 
in BAL 
bioreactor in the presence of epigallocatechin-3-gallate (EGCG) was
 studied. In this 
chapter, the preservation experiment in 3D BAL system was conducte
d after the effect 
of EGCG on hepatocyte preservation at room temperature was evaluat
ed by monolayer 
culture. The effect ofEGCG concentration. monolayer and spheroid-cu
lture. and culture 
medium on hepatocyte functions were studied and will be discussed in t
his chapter. 
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Part I: Manipulating cardiol1zyocytes 
Chapter 1 
Beating behavior of neonatal cardiomyocytes in different 
ECM matrices 
1.1 Introduction 
Cardiac tissue engineering such as cardiomyocyte transplantation for patients 
with ischemic heart disease or dilated cardiomyopathies, is of great potential therapeutic 
value to enhance the contractile function of the failing heart. However, the best cell 
sources for cI inical cardiomyocyte transplantation are still under debate. 
In this decade, fetal or neonatal rat cardiomyocytes were reported to form 
mature cardiac tissue in syngeneic heart, acutely injured myocardium, and granulation 
tissue in the heart [I]. Rather neonatal cardiomyocytes will be used for the clinical 
transplantations or not, the most crucial part is how to maintain the beating duration of 
neonatal cardiomyocytes in vitro. As we know, the substrate microenvironment or niche 
proves to play an important role in providing essential signals to influence major 
intracellular pathways such as proliferation, differentiation and cell metabolism in vitro. 
The effect of extracellular matrix (ECM) proteins such as collagen type I, collagen type 
IV, gelatin, laminin, fibronectin, Matrigel (a mixture of laminin, collagen type IV, 
heparan sulfate proteoglycans and entactin), and Cardiogcl (mixture of collagen type I 
and III, glycoproteins, laminin, fibronectin and proteoglycans) on cell viability, 
proliferation rate, and cardiomyocyte gene expression were reported [2-3]. However, the 
effect of ECM on duration of isolated cardiomyocytes beating behavior and BMSCs 
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differentiation to cardiomyocytes has not fully been discussed. 
Therefore, the aim of this chapter was to investigate the beating duration or 
1 · t f' dl'Olllyocytes on different ECM proteins (gelatin. fibronectin, and )eatmg ra e 0 edr c 
collagen type J) with respect to intracellular cardiac marker genes (troponin T type-2 
and troponin C type-I) [4] and cardiac differentiation marker gene (troponin C type-2) 
[5]. 
1.2 Matcrials and mcthods 
1.2.1 Cardiomyoctes 
Cardiomyocytes were isolated from neonatal Sprague-Dawley (SO) rat heart (I 
to 2-day-old) by the collagenase digestion method with modifications [6-7]. The hearts 
were removed and carefully minced with a scalpel blade into fragment and were rinsed 
several times with Hanks' balanced salt solution (Sigma-Adrich Inc. St. Louis. 1\/10) to 
remove blood and cellular debris. The minced hearts were gently stirred in 50 ml 
collagenase solution (0.15 M Sodium Chloride (NaC!). 5.63 mM Potassium Chloride 
(KCI), 0.02 M 4-(2-hydroxyethyl)- I -piperazineethanesulfunic acid (HEPES). 0.02 ivl  
Sodium Hydrogen Carbonate (NaHCO~), 3.74 mM Calcium Chloride Dihydrate 
(CaCb'2H20), and 6.5 x I04 U collagenase (Wako, Ltd., Osaka. Japan. Lot no: 
06032W)) at 37°C for 30 minutes. The resulting cell suspension was filtered through a 
nylon ceII strainer (BD Falcon, BD Biosciences, Bedford) with a 40 ~m pore size and 
centrifuged at 1000 rpm (78g) for 3 minutes. 
Isolated cardiomyocytes (I.O x 105) were cultured in mlllimum essential 
medium alpha medium (a-MEM, Gibco. Invitrogen Co., Grand Island, NY) 
supplemented with IO % (v/v) fetal bovine senlm (FBS. MP Biomedicals Inc .. 
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Eschwege, Germany, Lot no: 7297H), and 100 lUlL penicillin-streptomycin (Wako, Ltd., 
Osaka, Japan) on 60 mm gelatin- (IWAKI, Asahi Glass Co.,LTD., Tokyo, Japan), 
fibronectin- (BD Falcon TM, BO BioCoat, New Jersey), collagen type I-coated dish and 
non-coated polystyrene dish (IWAKI, Asahi Glass Co.,LTD., Tokyo, Japan). 
1.2.2 Measurement of action potential 
Cultured plates on which beating colonies appeared were placed on stage of an 
inverted phase-contrast optical microscope (ZEISS, Axiovert 135, Munich, Germany) 
and action potentials were measured immediately by conventional microelectrode. 
The measurements were conducted after 1, 2, and 3 weeks cultivation. Silicon coated 
Ag wire (A-M system, Inc., Carlsborg, Washington, 250 11m bare, 330 11m coated) was 
used as microelectrode. The microelectrode was set in a micromanipulator system 
(MON-202D, Nikon Narishige Co., Ltd., Tokyo, Japan) and connected to a bioelectric 
amplifier (AB-621 G, Nihon Kohde Co., Osaka, Japan). The sensitivity and time 
constant of bioelectric ampl ifier were set at 0.1 m V / div and 0.003 s. For the 
measurement, microelectrode was adjusted using micromanipulator until it was attached 
to the membrane of beating cells. The voltage difference was amplified with bioelectric 
amplifier, as well as displayed and recorded with Chart 5 software (AD Instrument, 
Bella Vista, Australia). 
1.2.3 Total RNA isolation and reverse trallscriptioll 
Total RNAs of cardiomyocytes cultured on various dishes were extracted by 
QuickGene RNA cultured cell kit S (Fujifilm Life Science, Tokyo, Japan) 4 weeks after 
culture, respectively. First-strand cDNAs were synthesized using a mixture of 
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· (dT) . Total cellular RNAs (200 ng) were incubated with 2.5 11M o Igo I R pmner. 
oligo(dT)Il~ primer at 70°C for 10 minutes to denature RNA secondary structure and 
then incubated at 4 °C to let the primer anneal to the RNA. A givent amount of 5X RT 
buffer (TOYOBO Co., Ltd., Osaka, Japan) and 2.5 mM deoxynucleotide trisphosphate 
(dNTP) mixture (Takara Bio Inc., Shiga, Japan) (4 Ill) were added and incubated at 37 
°C for 5 minutes. The reverse transcriptase (100 Units, TOYOBO Co., Ltd., Osaka, 
Japan) were added into the mixture and reverse transcriptase (RT) reaction was 
extended at 37°C for 1 hour. Then, the reaction mixture was heated at 94 °T for 5 
 minutes to inactivate the enzyme and cooled at 4 'C for 15 minutes. The RNase 
(DNase-free, 0.5 pg, Roche Diagnostics GmbH, Mannheim, Gemlany) was added into 
the mixture and incubated at 37°C to remove the template of RNA. 
1.2.4 Real-time qualltitath'e po(vmerase chaill reactioll (peR) 
Real-time quantitative polymerase chain reaction (PCR) was conducted with 
SYBR Green. Primers for PCR analysis for troponin T type-2, troponin C type-I, and 
troponin C type-2 were designed using Primer Express software (Perkin-Elmer Applied 
Biosystems, Cheshire, UK). Primer sequences arc shown in Tab. 1-1. Reaction mixtures 
contained 23.74 pi distilled water, 25 pi SYBR Green Realtime PCR master mix  
(TOYOBO Co., Ltd, Osaka, Japan), 100 n1vl of each primer, and 0.26 pi cDNA. The . 
themlal profile for PCR was 50 'C for 2 min, followed by 95 'C for 10 min, followed by ' 
40 cycles of 15 s at 95°C and I min at 60 dc. Distilled water 0.26 pi was used as a 
negative control PCR reaction to ensure the absence of template contamination in PCR 
reagents. The average threshold cycle (Ct) values of triplicate measurements were used 
for all subsequent calculations on the basis of the delta Ct method. 
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Tab. 1-1. Polymerase chain reaction primers used in this study. 
Genes Sens Anti-sens 
Troponin T type-2 5'-GAAACAGGATCAACGACAACCA-3' 5'-CGCCCGGTGACTITGG-3' 
Troponin C type-1 5'-GATCTCTTCCGCATGTTIGACA-3' 5'-TGGCCTGCAGCATCATCTT-3' 
Troponin C type-2 5'-AGATCGAATCCCTGATGAAGGA-3' 5'-CATCTTCAGAAACTCGTCGAAGTC-3' 
GAPDH 5'-CTACCCCCAATGTATCCGTTGT-3' 5'-TAGCCCAGGATGCCCTTTAGT-3' 
1.3 Results: 
1.3.1 Beatillg behavior of isolated cardiom),ocytes 
One week after culture, the action potential of cardiomyocytes on 
gelatin-coated dishes was higher than that for other conditions (Fig. I - I), and the 
beating duration was also longer than that for other conditions. The action potential and 
beating rates on each matrix are summarized in Tab. 1-2. After 7 days of culture, the 
action potential was around 6.7 ± 0.49 m V, for cardiomyocytes cultured on 
gelatin-coated dishes, 1.1 ± 0.97 mV on fibronectin-coated dishes, 2.0 ± 0.35 mV on 
collagen type I-coated dishes, and 2.0 ± 0.75 mV on noncoated polystyrene dishes. 
These results indicate that the action potential rate on fibronectin-, collagen type 
I-coated dishes and noncoated polystyrene dishes were 84%, 61 %, and 70% lower than 
gelatin-coated dishes after 1 week of cultivation. 
After 14 days of culture, the action potential became 6.6 ± 1.26 m V on 
gelatin-coated dishes, 6.9 ± 1. I 5 111 V on fibronectin-coated dishes, and 1.7 ± 0.03 m V 
on collagen type I-coated dishes. These mean the action potential rate on fibronectin-. 
and collagen type I-coated dishes were 5% higher, and 74% lower than gelatin-coated 
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Fig. 1-1. Electrophysiological assessment of isolated cardiomyocytes after 7 and 21 
days of cultivation on different substrates. 
After 2 I days of culture, the action potential was 3.1 ± 0.2 I m V on 
gelatin-coated and 2.8 ± O. 11m Von fibroncctin-coated dishes, signifying that the action 
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potential on fibronectin-coated dishes was 10% lower than gelatin-coated dish. No 
action potential was detected on collagen type I-coated dishes and polystyrene dishes 
after 21 days of cultivation. 
The beating rate of cardiomyocyte was also affected by the Ectv1 proteins. 
After 7 days of culture, the beating rate was 1.2 ± 0.05 Hz for cardiomyocyte cultured 
on gelatin-coated dishes, 1.1 ± 0.3 Hz on fibronectin-coated dishes, 0.8 ± 0.02. Hz on 
collagen type I-coated dishes and 0.3 ± 0.04 Hz on non coated polystyrene dishes. After 
14 days of culture, the beating rate became 1.3 ± 0.0 I Hz on gelatin-coated dishes, 1.3 ± 
0.42 Hz on fibronectin-coated dishes, and 2.3 ± 0.05 Hz on collagen type I-coated 
dishes. After 21 days, the beating rate was 2.8 ± 0.03 Hz on gelatin-coated dishes and 
2.0 ± 0.11 Hz on fibronectin-coated dishes, whereas, cardiomyocytes cultured on 
polystyrene dishes and collagen type I-coated dishes did not beat well and stopped at an 
early stage of cultivation. These results indicated that. gelatin could maintain the action 
potential of cardiomyocytes at high value for 2 weeks compared to fibronectin and 
collagen type-I. 
Tab. 1-2. Summary of voltage potential in several types of EeM-coated dish. 
Substrate 
Gelatin 
Fibronectin 
Day 7 
6.7 ± 0.49 [ 1.2 ± 0.05] 
1.1 ± 0.97 [1.1 ± 0.30] 
Collagen type-I 2.6 ± 0.35 [ 0.8 ± 0.02 ] 
Polystyrene 2.0 ± 0.75 [ 0.3 ± 0.04 ] 
Action potential (mV ) [Beating rate ( Hz) J 
Day 14 
6.6 ± 1.26 [ 1.3 ± 0.01] 
6.9 ± 1.15 [1.3 ± 0.42] 
1.7 ± 0.03 [2.3 ± 0.05] 
NO 
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Day 21 
3.1 ± 0.21[ 2.8:: 0.03] 
2.8 ± 0.11 [2.0:: 0.11 ] 
NO 
NO 
